Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Feb. 29, 2016	May. 31, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 12,190	$ 18,363
Trade accounts receivable, net of allowance for doubtful accounts of $1,978 and $1,669 at February 29, 2016 and May 31, 2015, respectively	59,970	67,674
Inventories, net	47,844	41,847
Deferred income tax assets, current portion	6,021	5,931
Prepaid expenses and other current assets	9,817	11,161
Total current assets	135,842	144,976
PROPERTY AND EQUIPMENT, net	72,788	73,574
GOODWILL	840,841	842,258
INTANGIBLE ASSETS, net	608,832	650,294
DEFERRED FINANCING COSTS, net	21,072	26,399
OTHER ASSETS	17,305	15,185
Total assets	1,696,680	1,752,686
CURRENT LIABILITIES:
Accounts payable	17,555	13,866
Accrued interest and interest rate swap liability	7,764	19,288
Accrued expenses and other current liabilities	19,503	26,208
Income taxes payable	3,108	3,496
Deferred revenue, current portion	2,656	2,703
Current portion of long-term debt, net of debt discounts	8,878	4,469
Total current liabilities	59,464	70,030
LONG-TERM DEBT, net of debt discounts	1,030,478	1,033,276
DEFERRED INCOME TAX LIABILITIES	219,351	236,487
OTHER LONG-TERM LIABILITIES	30,765	29,212
Total liabilities	$ 1,340,058	$ 1,369,005
COMMITMENTS AND CONTINGENCIES (Note 19)
Shareholders' equity of Immucor, Inc.:
Common stock, $0.00 par value, 100 shares authorized, issued and outstanding as of February 29, 2016 and May 31, 2015, respectively
Additional paid-in capital	$ 753,279	$ 755,234
Accumulated deficit	(359,425)	(331,989)
Accumulated other comprehensive loss	(42,995)	(39,564)
Total shareholders' equity of Immucor, Inc.	350,859	$ 383,681
Equity of noncontrolling interest (Note 4)	5,763
Total equity	356,622	$ 383,681
Total liabilities and equity	$ 1,696,680	$ 1,752,686